{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:48:26Z","timestamp":1794271706272,"version":"4.9.0"},"reference-count":182,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T00:00:00Z","timestamp":1595289600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.biopha.2020.110542","type":"journal-article","created":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T06:16:22Z","timestamp":1596003382000},"page":"110542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":248,"special_numbering":"C","title":["Role of the NLRP3 inflammasome in autoimmune diseases"],"prefix":"10.1016","volume":"130","author":[{"given":"Zhe","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqi","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.biopha.2020.110542_bib0005","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.biopha.2020.110542_bib0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3349\/ymj.2016.57.1.5","article-title":"NOD-like receptors in infection, immunity, and diseases","volume":"57","author":"Kim","year":"2016","journal-title":"Yonsei Med. J."},{"issue":"9","key":"10.1016\/j.biopha.2020.110542_bib0015","doi-asserted-by":"crossref","DOI":"10.1038\/nrd.2018.149","article-title":"Targeting the NLRP3 inflammasome in inflammatory diseases","volume":"17","author":"Mangan","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"8","key":"10.1016\/j.biopha.2020.110542_bib0020","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2020.110542_bib0025","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"issue":"43","key":"10.1016\/j.biopha.2020.110542_bib0030","article-title":"The NLRP3 and pyrin inflammasomes: implications in the pathophysiology of autoinflammatory diseases","volume":"8","author":"de Torre-Minguela","year":"2017","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.biopha.2020.110542_bib0035","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.tibs.2016.09.002","article-title":"Mechanism and regulation of NLRP3 inflammasome activation","volume":"41","author":"He","year":"2016","journal-title":"Trends Biochem. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2020.110542_bib0040","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/ni.3123","article-title":"Control of adaptive immunity by the innate immune system","volume":"16","author":"Iwasaki","year":"2015","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2020.110542_bib0045","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jmb.2017.09.019","article-title":"How inflammasomes inform adaptive immunity","volume":"430","author":"Evavold","year":"2018","journal-title":"J. Mol. Biol."},{"issue":"9894","key":"10.1016\/j.biopha.2020.110542_bib0050","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0140-6736(13)60954-X","article-title":"Immunopathogenic mechanisms of systemic autoimmune disease","volume":"382","author":"Wahren-Herlenius","year":"2013","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.biopha.2020.110542_bib0055","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1038\/s41467-018-04581-2","article-title":"Macrophage migration inhibitory factor is required for NLRP3 inflammasome activation","volume":"9","author":"Lang","year":"2018","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.biopha.2020.110542_bib0060","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4049\/jimmunol.0901363","article-title":"Cutting edge: NF-\u03baB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression","volume":"183","author":"Bauernfeind","year":"2009","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2020.110542_bib0065","doi-asserted-by":"crossref","first-page":"792","DOI":"10.4049\/jimmunol.0900173","article-title":"Cutting edge: TNF-\u03b1 mediates sensitization to ATP and silica via the NLRP3 inflammasome in the absence of microbial stimulation","volume":"183","author":"Franchi","year":"2009","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2020.110542_bib0070","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.cell.2014.02.008","article-title":"Unified polymerization mechanism for the assembly of ASC-dependent inflammasomes","volume":"156","author":"Lu","year":"2014","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.biopha.2020.110542_bib0075","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1084\/jem.20172222","article-title":"Caspase-1 self-cleavage is an intrinsic mechanism to terminate inflammasome activity","volume":"215","author":"Boucher","year":"2018","journal-title":"J. Exp. Med."},{"issue":"7575","key":"10.1016\/j.biopha.2020.110542_bib0080","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nature15514","article-title":"Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death","volume":"526","author":"Shi","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2020.110542_bib0085","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.bcp.2017.12.021","article-title":"The P2X7 receptor: a main player in inflammation","volume":"151","author":"Adinolfi","year":"2018","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110542_bib0090","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1074\/jbc.C115.700492","article-title":"A genome-wide CRISPR (Clustered regularly interspaced short palindromic repeats) screen identifies NEK7 as an essential component of NLRP3 inflammasome activation","volume":"291","author":"Schmid-Burgk","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"7590","key":"10.1016\/j.biopha.2020.110542_bib0095","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/nature16959","article-title":"NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux","volume":"530","author":"He","year":"2016","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.biopha.2020.110542_bib0100","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.tcb.2016.03.006","article-title":"Digesting the expanding mechanisms of autophagy","volume":"26","author":"Ktistakis","year":"2016","journal-title":"Trends Cell Biol."},{"issue":"11","key":"10.1016\/j.biopha.2020.110542_bib0105","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/abbs\/gmz098","article-title":"Interaction between autophagy and the NLRP3 inflammasome","volume":"51","author":"Cao","year":"2019","journal-title":"Acta Biochim. Biophys. Sin."},{"issue":"3","key":"10.1016\/j.biopha.2020.110542_bib0110","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/ni.2215","article-title":"Activation of autophagy by inflammatory signals limits IL-1\u03b2 production by targeting ubiquitinated inflammasomes for destruction","volume":"13","author":"Shi","year":"2012","journal-title":"Nat. Immunol."},{"issue":"7329","key":"10.1016\/j.biopha.2020.110542_bib0115","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature09663","article-title":"A role for mitochondria in NLRP3 inflammasome activation","volume":"469","author":"Zhou","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2020.110542_bib0120","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mito.2017.10.009","article-title":"Mitophagy and the release of inflammatory cytokines","volume":"41","author":"Harris","year":"2018","journal-title":"Mitochondrion"},{"issue":"3","key":"10.1016\/j.biopha.2020.110542_bib0125","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/ni.1980","article-title":"Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome","volume":"12","author":"Nakahira","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biopha.2020.110542_bib0130","doi-asserted-by":"crossref","first-page":"101254","DOI":"10.1016\/j.redox.2019.101254","article-title":"PINK1-parkin pathway of mitophagy protects against contrast-induced acute kidney injury via decreasing mitochondrial ROS and NLRP3 inflammasome activation","volume":"26","author":"Lin","year":"2019","journal-title":"Redox Biol."},{"issue":"7","key":"10.1016\/j.biopha.2020.110542_bib0135","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1002\/jcp.24903","article-title":"Resveratrol inhibits NLRP3 inflammasome activation by preserving mitochondrial integrity and augmenting autophagy","volume":"230","author":"Chang","year":"2015","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110542_bib0140","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/JLB.3MA0320-358RR","article-title":"Berberine suppresses influenza virus-triggered NLRP3 inflammasome activation in macrophages by inducing mitophagy and decreasing mitochondrial ROS","volume":"108","author":"Liu","year":"2020","journal-title":"J. Leukoc. Biol."},{"issue":"6","key":"10.1016\/j.biopha.2020.110542_bib0145","doi-asserted-by":"crossref","first-page":"972","DOI":"10.4161\/auto.28374","article-title":"Small molecule-driven mitophagy-mediated NLRP3 inflammasome inhibition is responsible for the prevention of colitis-associated cancer","volume":"10","author":"Guo","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.biopha.2020.110542_bib0150","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.brainres.2019.01.005","article-title":"Rapamycin improves the neuroprotection effect of inhibition of NLRP3 inflammasome activation after TBI","volume":"1710","author":"Chen","year":"2019","journal-title":"Brain Res."},{"key":"10.1016\/j.biopha.2020.110542_bib0155","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.3389\/fphar.2019.01292","article-title":"Rapamycin attenuates high glucose-induced inflammation through modulation of mTOR\/NF-\u03baB pathways in macrophages","volume":"10","author":"Dai","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2020.110542_bib0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2019.152304","article-title":"Zearalenone induces NLRP3-dependent pyroptosis via activation of NF-\u03baB modulated by autophagy in INS-1 cells","volume":"428","author":"Wang","year":"2019","journal-title":"Toxicology"},{"issue":"2","key":"10.1016\/j.biopha.2020.110542_bib0165","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4049\/jimmunol.0901363","article-title":"Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression","volume":"183","author":"Bauernfeind","year":"2009","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2020.110542_bib0170","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1073\/pnas.1320294111","article-title":"IRAK-1 bypasses priming and directly links TLRs to rapid NLRP3 inflammasome activation","volume":"111","author":"Lin","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.biopha.2020.110542_bib0175","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.4049\/jimmunol.1301681","article-title":"Cutting edge: TLR signaling licenses IRAK1 for rapid activation of the NLRP3 inflammasome","volume":"191","author":"Fernandes-Alnemri","year":"2013","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2020.110542_bib0180","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.4049\/jimmunol.1302839","article-title":"FADD and caspase-8 mediate priming and activation of the canonical and noncanonical Nlrp3 inflammasomes","volume":"192","author":"Gurung","year":"2014","journal-title":"J. Immunol. (Baltim. Md.: 1950)"},{"issue":"52","key":"10.1016\/j.biopha.2020.110542_bib0185","doi-asserted-by":"crossref","first-page":"15078","DOI":"10.1073\/pnas.1618773114","article-title":"TIFA as a crucial mediator for NLRP3 inflammasome","volume":"113","author":"Lin","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.biopha.2020.110542_bib0190","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/s41467-019-09482-6","article-title":"The lncRNA Neat1 promotes activation of inflammasomes in macrophages","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.biopha.2020.110542_bib0195","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.4049\/jimmunol.1201516","article-title":"NLRP3 inflammasome activity is negatively controlled by miR-223","volume":"189","author":"Bauernfeind","year":"2012","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2020.110542_bib0200","first-page":"3318","article-title":"MicroRNA\u201133 regulates the NLRP3 inflammasome signaling pathway in macrophages","volume":"17","author":"Xie","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"3","key":"10.1016\/j.biopha.2020.110542_bib0205","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.trsl.2012.04.002","article-title":"Circulating microRNAs as candidate biomarkers in patients with systemic lupus erythematosus","volume":"160","author":"Wang","year":"2012","journal-title":"Transl. Res.: J. Lab. Clin. Med."},{"issue":"1","key":"10.1016\/j.biopha.2020.110542_bib0210","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/cmi.2016.29","article-title":"Post-translational regulation of inflammasomes","volume":"14","author":"Yang","year":"2017","journal-title":"Cell. Mol. Immunol."},{"issue":"43","key":"10.1016\/j.biopha.2020.110542_bib0215","doi-asserted-by":"crossref","first-page":"36617","DOI":"10.1074\/jbc.M112.407130","article-title":"Non-transcriptional priming and deubiquitination regulate NLRP3 inflammasome activation","volume":"287","author":"Juliana","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2020.110542_bib0220","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/s41467-018-03669-z","article-title":"The E3 ubiquitin ligase Pellino2 mediates priming of the NLRP3 inflammasome","volume":"9","author":"Humphries","year":"2018","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.biopha.2020.110542_bib0225","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.molcel.2012.11.009","article-title":"Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity","volume":"49","author":"Py","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.biopha.2020.110542_bib0230","doi-asserted-by":"crossref","first-page":"13727","DOI":"10.1038\/ncomms13727","article-title":"The E3 ubiquitin ligase TRIM31 attenuates NLRP3 inflammasome activation by promoting proteasomal degradation of NLRP3","volume":"7","author":"Song","year":"2016","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.biopha.2020.110542_bib0235","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.4049\/jimmunol.1700184","article-title":"ARIH2 ubiquitinates NLRP3 and negatively regulates NLRP3 inflammasome activation in macrophages","volume":"199","author":"Kawashima","year":"2017","journal-title":"J. Immunol."},{"issue":"1-2","key":"10.1016\/j.biopha.2020.110542_bib0240","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cell.2014.11.047","article-title":"Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome","volume":"160","author":"Yan","year":"2015","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.biopha.2020.110542_bib0245","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/ni.3538","article-title":"NLRP3 inflammasome inhibition is disrupted in a group of auto-inflammatory disease CAPS mutations","volume":"17","author":"Mortimer","year":"2016","journal-title":"Nat. Immunol."},{"issue":"9","key":"10.1016\/j.biopha.2020.110542_bib0250","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1084\/jem.20162040","article-title":"Protein kinase D at the Golgi controls NLRP3 inflammasome activation","volume":"214","author":"Zhang","year":"2017","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.biopha.2020.110542_bib0255","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.molcel.2017.08.017","article-title":"NLRP3 phosphorylation is an essential priming event for inflammasome activation","volume":"68","author":"Song","year":"2017","journal-title":"Mol. Cell"},{"issue":"5","key":"10.1016\/j.biopha.2020.110542_bib0260","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1172\/JCI83669","article-title":"NLRP3 tyrosine phosphorylation is controlled by protein tyrosine phosphatase PTPN22","volume":"126","author":"Spalinger","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.biopha.2020.110542_bib0265","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1084\/jem.20160933","article-title":"NLRP3 inflammasome assembly is regulated by phosphorylation of the pyrin domain","volume":"214","author":"Stutz","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biopha.2020.110542_bib0270","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3389\/fphar.2019.00451","article-title":"MicroRNA post-transcriptional regulation of the NLRP3 inflammasome in Immunopathologies","volume":"10","author":"Tezcan","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110542_bib0275","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jaci.2016.05.016","article-title":"DNA demethylation of inflammasome-associated genes is enhanced in patients with cryopyrin-associated periodic syndromes","volume":"139","author":"Vento-Tormo","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.biopha.2020.110542_bib0280","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4323281","article-title":"NLRP3 activation was regulated by DNA methylation modification during Mycobacterium tuberculosis infection","volume":"2016","author":"Wei","year":"2016","journal-title":"Biomed Res. Int."},{"issue":"2","key":"10.1016\/j.biopha.2020.110542_bib0285","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/onc.2009.334","article-title":"Histone deacetylases and the immunological network: implications in cancer and inflammation","volume":"29","author":"Villagra","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2020.110542_bib0290","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.expneurol.2018.01.011","article-title":"Upregulation of NLRP3 via STAT3-dependent histone acetylation contributes to painful neuropathy induced by bortezomib","volume":"302","author":"Liu","year":"2018","journal-title":"Exp. Neurol."},{"issue":"12","key":"10.1016\/j.biopha.2020.110542_bib0295","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.tibs.2016.09.002","article-title":"Mechanism and regulation of NLRP3 inflammasome activation","volume":"41","author":"He","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.biopha.2020.110542_bib0300","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.immunol.021908.132612","article-title":"Immunological and inflammatory functions of the interleukin-1 family","volume":"27","author":"Dinarello","year":"2009","journal-title":"Annu. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2020.110542_bib0305","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.immuni.2013.11.010","article-title":"The interleukin-1 family: back to the future","volume":"39","author":"Garlanda","year":"2013","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.biopha.2020.110542_bib0310","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190314","article-title":"Inflammasome signaling and regulation of interleukin-1 family cytokines","volume":"217","author":"Chan","year":"2020","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.biopha.2020.110542_bib0315","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00281-016-0583-z","article-title":"Dendritic cells as gatekeepers of tolerance","volume":"39","author":"Waisman","year":"2017","journal-title":"Semin. Immunopathol."},{"issue":"13","key":"10.1016\/j.biopha.2020.110542_bib0320","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1111\/febs.14467","article-title":"A Guide to IL-1 family cytokines in adjuvanticity","volume":"285","author":"Mu\u00f1oz-Wolf","year":"2018","journal-title":"FEBS J."},{"issue":"9","key":"10.1016\/j.biopha.2020.110542_bib0325","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/ni1496","article-title":"Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells","volume":"8","author":"Acosta-Rodriguez","year":"2007","journal-title":"Nat. Immunol."},{"issue":"9","key":"10.1016\/j.biopha.2020.110542_bib0330","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/ni1497","article-title":"Development, cytokine profile and function of human interleukin 17-producing helper T cells","volume":"8","author":"Wilson","year":"2007","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110542_bib0335","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/s41467-019-09401-9","article-title":"IL-4 together with IL-1\u03b2 induces antitumor Th9 cell differentiation in the absence of TGF-\u03b2 signaling","volume":"10","author":"Xue","year":"2019","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.biopha.2020.110542_bib0340","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s41423-018-0004-4","article-title":"When worlds collide: Th17 and Treg cells in cancer and autoimmunity","volume":"15","author":"Knochelmann","year":"2018","journal-title":"Cell. Mol. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2020.110542_bib0345","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.humimm.2016.12.010","article-title":"Th9 cells and IL-9 in autoimmune disorders: pathogenesis and therapeutic potentials","volume":"78","author":"Deng","year":"2017","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.biopha.2020.110542_bib0350","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1101\/sqb.2013.78.021246","article-title":"IL-1\u03b2 strikingly enhances antigen-driven CD4 and CD8 T-cell responses","volume":"78","author":"Ben-Sasson","year":"2013","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"issue":"3","key":"10.1016\/j.biopha.2020.110542_bib0355","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1084\/jem.20122006","article-title":"IL-1 enhances expansion, effector function, tissue localization, and memory response of antigen-specific CD8 T cells","volume":"210","author":"Ben-Sasson","year":"2013","journal-title":"J. Exp. Med."},{"issue":"10","key":"10.1016\/j.biopha.2020.110542_bib0360","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1128\/iai.63.10.3966-3972.1995","article-title":"A novel costimulatory factor for gamma interferon induction found in the livers of mice causes endotoxic shock","volume":"63","author":"Okamura","year":"1995","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.biopha.2020.110542_bib0365","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1359-6101(00)00015-0","article-title":"Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu","volume":"12","author":"Nakanishi","year":"2001","journal-title":"Cytokine Growth Factor Rev."},{"issue":"5","key":"10.1016\/j.biopha.2020.110542_bib0370","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1159\/000477172","article-title":"Combined stimulation with Interleukin-18 and Interleukin-12 potently induces Interleukin-8 production by natural killer cells","volume":"9","author":"Poznanski","year":"2017","journal-title":"J. Innate Immun."},{"issue":"6","key":"10.1016\/j.biopha.2020.110542_bib0375","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/mi.2015.13","article-title":"Epithelial-derived IL-18 regulates Th17 cell differentiation and Foxp3+ Treg cell function in the intestine","volume":"8","author":"Harrison","year":"2015","journal-title":"Mucosal Immunol."},{"issue":"11","key":"10.1016\/j.biopha.2020.110542_bib0380","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/nrendo.2013.161","article-title":"Clinical implications of shared genetics and pathogenesis in autoimmune diseases","volume":"9","author":"Zhernakova","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"issue":"3","key":"10.1016\/j.biopha.2020.110542_bib0385","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1515\/jomb-2016-0008","article-title":"NLRP3 and CARD8 polymorphisms influence higher disease activity in rheumatoid arthritis","volume":"35","author":"Jenko","year":"2016","journal-title":"J. Med. Biochem."},{"issue":"4","key":"10.1016\/j.biopha.2020.110542_bib0390","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1136\/ard.2008.106989","article-title":"CARD8 p.C10X polymorphism is associated with inflammatory activity in early rheumatoid arthritis","volume":"69","author":"Kastbom","year":"2010","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.biopha.2020.110542_bib0395","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00011-017-1119-2","article-title":"Polymorphisms and expression of inflammasome genes are associated with the development and severity of rheumatoid arthritis in Brazilian patients","volume":"67","author":"Addobbati","year":"2018","journal-title":"Inflamm. Res."},{"issue":"6","key":"10.1016\/j.biopha.2020.110542_bib0400","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100361","article-title":"Anti-TNF treatment response in rheumatoid arthritis patients is associated with genetic variation in the NLRP3-inflammasome","volume":"9","author":"Sode","year":"2014","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.biopha.2020.110542_bib0405","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139781","article-title":"Genetic variations in pattern recognition receptor loci are associated with anti-TNF response in patients with rheumatoid arthritis","volume":"10","author":"Sode","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.biopha.2020.110542_bib0410","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00251-020-01158-6","article-title":"Differential expression of the inflammasome complex genes in systemic lupus erythematosus","volume":"72","author":"da Cruz","year":"2020","journal-title":"Immunogenetics"},{"key":"10.1016\/j.biopha.2020.110542_bib0415","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1471-2350-13-107","article-title":"Association of IL-18 polymorphisms with rheumatoid arthritis and systemic lupus erythematosus in Asian populations: a meta-analysis","volume":"13","author":"Chen","year":"2012","journal-title":"BMC Med. Genet."},{"issue":"1","key":"10.1016\/j.biopha.2020.110542_bib0420","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3109\/08830185.2013.816699","article-title":"Association of interleukin-18 (-137G\/C) polymorphism with rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis","volume":"33","author":"Wen","year":"2014","journal-title":"Int. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2020.110542_bib0425","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1007\/s11033-012-2344-y","article-title":"Association between interleukin-18 polymorphisms and systemic lupus erythematosus: a meta-analysis","volume":"40","author":"Song","year":"2013","journal-title":"Mol. Biol. Rep."},{"issue":"7","key":"10.1016\/j.biopha.2020.110542_bib0430","first-page":"434","article-title":"Inflammasome polymorphisms in juvenile systemic lupus erythematosus","volume":"48","author":"Pontillo","year":"2015","journal-title":"Autoimmunity"},{"issue":"6","key":"10.1016\/j.biopha.2020.110542_bib0435","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22138","article-title":"The association of NLRP3 and TNFRSF1A polymorphisms with risk of ankylosing spondylitis and treatment efficacy of etanercept","volume":"31","author":"Zhao","year":"2017","journal-title":"J. Clin. Lab. Anal."},{"issue":"6","key":"10.1016\/j.biopha.2020.110542_bib0440","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3109\/03009742.2013.779020","article-title":"Genetic variants in CARD8 but not in NLRP3 are associated with ankylosing spondylitis","volume":"42","author":"Kastbom","year":"2013","journal-title":"Scand. J. Rheumatol."},{"issue":"7","key":"10.1016\/j.biopha.2020.110542_bib0445","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1002\/art.23604","article-title":"Autoinflammatory genes and susceptibility to psoriatic juvenile idiopathic arthritis","volume":"58","author":"Day","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"10055","key":"10.1016\/j.biopha.2020.110542_bib0450","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.biopha.2020.110542_bib0455","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/cei.13167","article-title":"NLRP3 inflammasome activation contributes to the pathogenesis of rheumatoid arthritis","volume":"194","author":"Guo","year":"2018","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110542_bib0460","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-015-0775-2","article-title":"Enhanced activity of NLRP3 inflammasome in peripheral blood cells of patients with active rheumatoid arthritis","volume":"17","author":"Choulaki","year":"2015","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2020.110542_bib0465","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/cei.12667","volume":"182","author":"Ruscitti","year":"2015","journal-title":"Clin. Exp. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2020.110542_bib0470","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1365-2567.2009.03174.x","article-title":"Expression and function of the NALP3 inflammasome in rheumatoid synovium","volume":"129","author":"Kolly","year":"2010","journal-title":"Immunology"},{"issue":"8","key":"10.1016\/j.biopha.2020.110542_bib0475","doi-asserted-by":"crossref","first-page":"5320","DOI":"10.1074\/jbc.M113.505636","article-title":"Localization and functionality of the inflammasome in neutrophils","volume":"289","author":"Bakele","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.biopha.2020.110542_bib0480","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jbspin.2015.07.006","article-title":"Caspase-1 mediated interleukin-18 activation in neutrophils promotes the activity of rheumatoid arthritis in a NLRP3 inflammasome independent manner","volume":"83","author":"Yang","year":"2016","journal-title":"Jt. Bone Spine: Rev. Rhum."},{"key":"10.1016\/j.biopha.2020.110542_bib0485","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9656270","article-title":"NLRP3 inflammasome plays an important role in the pathogenesis of collagen-induced arthritis","volume":"2016","author":"Zhang","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.biopha.2020.110542_bib0490","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2016.00532","article-title":"Succinate\/NLRP3 inflammasome induces synovial fibroblast activation: therapeutical effects of clematichinenoside AR on arthritis","volume":"7","author":"Li","year":"2016","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.biopha.2020.110542_bib0495","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.442","article-title":"Human umbilical cord blood-stem cells direct macrophage polarization and block inflammasome activation to alleviate rheumatoid arthritis","volume":"7","author":"Shin","year":"2016","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.biopha.2020.110542_bib0500","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.joca.2006.04.008","article-title":"NF-kappaB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis","volume":"14","author":"Roman-Blas","year":"2006","journal-title":"Osteoarthr. Cartil."},{"issue":"7512","key":"10.1016\/j.biopha.2020.110542_bib0505","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nature13322","article-title":"Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis","volume":"512","author":"Vande Walle","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2020.110542_bib0510","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.intimp.2015.11.026","article-title":"The protective effects of curculigoside A on adjuvant-induced arthritis by inhibiting NF-\u043aB\/NLRP3 activation in rats","volume":"30","author":"Ding","year":"2016","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2020.110542_bib0515","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41423-019-0201-9","article-title":"ACPAs promote IL-1\u03b2 production in rheumatoid arthritis by activating the NLRP3 inflammasome","volume":"17","author":"Dong","year":"2020","journal-title":"Cell. Mol. Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2020.110542_bib0520","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.jbspin.2015.10.007","article-title":"MicroRNA-20a negatively regulates expression of NLRP3-inflammasome by targeting TXNIP in adjuvant-induced arthritis fibroblast-like synoviocytes","volume":"83","author":"Li","year":"2016","journal-title":"Jt. Bone Spine: Rev. Rhum."},{"issue":"1","key":"10.1016\/j.biopha.2020.110542_bib0525","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-01836-8","article-title":"Pro-inflammatory Ca(++)-activated K(+) channels are inhibited by hydroxychloroquine","volume":"7","author":"Eugenia Schroeder","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.biopha.2020.110542_bib0530","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41374-018-0135-3","article-title":"The role of Ca(2+) in acid-sensing ion channel 1a-mediated chondrocyte pyroptosis in rat adjuvant arthritis","volume":"99","author":"Wu","year":"2019","journal-title":"Lab. Invest."},{"issue":"12","key":"10.1016\/j.biopha.2020.110542_bib0535","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nrrheum.2016.186","article-title":"New insights into the immunopathogenesis of systemic lupus erythematosus","volume":"12","author":"Tsokos","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"issue":"22","key":"10.1016\/j.biopha.2020.110542_bib0540","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMra1100359","article-title":"Systemic lupus erythematosus","volume":"365","author":"Tsokos","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.biopha.2020.110542_bib0545","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/rheumatology\/keu318","article-title":"Sex-dependent differential activation of NLRP3 and AIM2 inflammasomes in SLE macrophages","volume":"54","author":"Yang","year":"2015","journal-title":"Rheumatology (Oxf. Engl.)"},{"key":"10.1016\/j.biopha.2020.110542_bib0550","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3389\/fphar.2019.00435","article-title":"P2X7 receptor expression in patients with serositis related to systemic lupus erythematosus","volume":"10","author":"Furini","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2020.110542_bib0555","article-title":"Expression of inflammasomes NLRP1, NLRP3 and AIM2 in different pathologic classification of lupus nephritis","author":"Huang","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"issue":"8","key":"10.1016\/j.biopha.2020.110542_bib0560","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1002\/art.40155","article-title":"Podocyte activation of NLRP3 inflammasomes contributes to the development of proteinuria in lupus nephritis","volume":"69","author":"Fu","year":"2017","journal-title":"Arthritis Rheumatol. (Hoboken N.J.)"},{"issue":"4","key":"10.1016\/j.biopha.2020.110542_bib0565","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.4049\/jimmunol.1201195","article-title":"Self double-stranded (ds)DNA induces IL-1\u03b2 production from human monocytes by activating NLRP3 inflammasome in the presence of anti-dsDNA antibodies","volume":"190","author":"Shin","year":"2013","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110542_bib0570","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12967-016-0911-z","article-title":"Anti-dsDNA antibodies bind to TLR4 and activate NLRP3 inflammasome in lupus monocytes\/macrophages","volume":"14","author":"Zhang","year":"2016","journal-title":"J. Transl. Med."},{"issue":"10","key":"10.1016\/j.biopha.2020.110542_bib0575","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.4049\/jimmunol.1103355","article-title":"U1-small nuclear ribonucleoprotein activates the NLRP3 inflammasome in human monocytes","volume":"188","author":"Shin","year":"2012","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110542_bib0580","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/art.40672","article-title":"Macrophage migration inhibitory factor regulates U1 small nuclear RNP immune complex-mediated activation of the NLRP3 inflammasome","volume":"71","author":"Shin","year":"2019","journal-title":"Arthritis Rheumatol. (Hoboken, N.J.)"},{"issue":"2","key":"10.1016\/j.biopha.2020.110542_bib0585","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/nri.2017.105","article-title":"Neutrophil extracellular traps in immunity and disease","volume":"18","author":"Papayannopoulos","year":"2018","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2020.110542_bib0590","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.4049\/jimmunol.1202388","article-title":"Neutrophil extracellular trap-associated protein activation of the NLRP3 inflammasome is enhanced in lupus macrophages","volume":"190","author":"Kahlenberg","year":"2013","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.biopha.2020.110542_bib0595","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00109-016-1421-4","article-title":"Cause and consequences of the activated type I interferon system in SLE","volume":"94","author":"Eloranta","year":"2016","journal-title":"J. Mol. Med. (Berlin, Germany)"},{"issue":"5","key":"10.1016\/j.biopha.2020.110542_bib0600","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/art.21031","article-title":"Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease","volume":"52","author":"Kirou","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.biopha.2020.110542_bib0605","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1002\/art.40166","article-title":"Enhanced inflammasome activity in systemic lupus erythematosus is mediated via type I interferon-induced up-regulation of interferon regulatory factor 1","volume":"69","author":"Liu","year":"2017","journal-title":"Arthritis Rheumatol. (Hoboken, N.J.)"},{"issue":"11","key":"10.1016\/j.biopha.2020.110542_bib0610","doi-asserted-by":"crossref","first-page":"6143","DOI":"10.4049\/jimmunol.1101284","article-title":"Inflammasome activation of IL-18 results in endothelial progenitor cell dysfunction in systemic lupus erythematosus","volume":"187","author":"Kahlenberg","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2020.110542_bib0615","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.mce.2015.08.003","article-title":"Bisphenol A (BPA) stimulates the interferon signaling and activates the inflammasome activity in myeloid cells","volume":"415","author":"Panchanathan","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"issue":"3","key":"10.1016\/j.biopha.2020.110542_bib0620","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.4049\/jimmunol.1600659","article-title":"Hyperactivation of the NLRP3 inflammasome in myeloid cells leads to severe organ damage in experimental lupus","volume":"198","author":"Lu","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2020.110542_bib0625","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.05.014","article-title":"Pathogenesis of lupus nephritis: RIP3 dependent necroptosis and NLRP3 inflammasome activation","volume":"103","author":"Guo","year":"2019","journal-title":"J. Autoimmun."},{"issue":"12","key":"10.1016\/j.biopha.2020.110542_bib0630","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1002\/art.38174","article-title":"P2X7 blockade attenuates murine lupus nephritis by inhibiting activation of the NLRP3\/ASC\/caspase 1 pathway","volume":"65","author":"Zhao","year":"2013","journal-title":"Arthritis Rheum."},{"issue":"14","key":"10.1016\/j.biopha.2020.110542_bib0635","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20143466","article-title":"NLRP3 inflammasome modulation by melatonin supplementation in chronic pristane-induced lupus nephritis","volume":"20","author":"Bonomini","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2020.110542_bib0640","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3109\/08916934.2013.798651","article-title":"A novel antagonist of Toll-like receptors 7, 8 and 9 suppresses lupus disease-associated parameters in NZBW\/F1 mice","volume":"46","author":"Zhu","year":"2013","journal-title":"Autoimmunity"},{"key":"10.1016\/j.biopha.2020.110542_bib0645","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.intimp.2019.01.046","article-title":"Curcumin attenuates murine lupus via inhibiting NLRP3 inflammasome","volume":"69","author":"Zhao","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110542_bib0650","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13075-019-1876-0","article-title":"Baicalein ameliorates pristane-induced lupus nephritis via activating Nrf2\/HO-1 in myeloid-derived suppressor cells","volume":"21","author":"Li","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.biopha.2020.110542_bib0655","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.intimp.2018.10.025","article-title":"Piperine ameliorated lupus nephritis by targeting AMPK-mediated activation of NLRP3 inflammasome","volume":"65","author":"Peng","year":"2018","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2020.110542_bib0660","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s12026-018-9012-9","article-title":"Sophocarpine attenuates murine lupus nephritis via inhibiting NLRP3 inflammasome and NF-\u03baB activation","volume":"66","author":"Li","year":"2018","journal-title":"Immunol. Res."},{"key":"10.1016\/j.biopha.2020.110542_bib0665","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.lfs.2018.07.009","article-title":"Icariin alleviates murine lupus nephritis via inhibiting NF-\u03baB activation pathway and NLRP3 inflammasome","volume":"208","author":"Su","year":"2018","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.biopha.2020.110542_bib0670","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3899\/jrheum.130310","article-title":"Deregulated NLRP3 and NLRP1 inflammasomes and their correlations with disease activity in systemic lupus erythematosus","volume":"41","author":"Yang","year":"2014","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.biopha.2020.110542_bib0675","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12950-018-0192-9","article-title":"Expression and clinical significance of the NEK7-NLRP3 inflammasome signaling pathway in patients with systemic lupus erythematosus","volume":"15","author":"Ma","year":"2018","journal-title":"J. Inflamm. (Lond. Engl.)"},{"issue":"12","key":"10.1016\/j.biopha.2020.110542_bib0680","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1136\/annrheumdis-2014-205496","article-title":"NLRP3 and ASC suppress lupus-like autoimmunity by driving the immunosuppressive effects of TGF-\u03b2 receptor signalling","volume":"74","author":"Lech","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.biopha.2020.110542_bib0685","first-page":"16047","article-title":"Sj\u00f6gren syndrome, nature reviews","volume":"2","author":"Brito-Zer\u00f3n","year":"2016","journal-title":"Dis. Prim."},{"issue":"10","key":"10.1016\/j.biopha.2020.110542_bib0690","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMcp1702514","article-title":"Primary Sj\u00f6gren\u2019s syndrome","volume":"378","author":"Mariette","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2020.110542_bib0695","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cca.2017.09.019","article-title":"Enhanced expression of NLRP3 inflammasome-related inflammation in peripheral blood mononuclear cells in Sj\u00f6gren\u2019s syndrome","volume":"474","author":"Kim","year":"2017","journal-title":"Clin. Chim. Acta"},{"issue":"5","key":"10.1016\/j.biopha.2020.110542_bib0700","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126277","article-title":"Upregulation of NLRP3 inflammasome in the tears and ocular surface of dry eye patients","volume":"10","author":"Niu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2020.110542_bib0705","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jaut.2018.02.010","article-title":"Systemic activation of NLRP3 inflammasome in patients with severe primary Sj\u00f6gren\u2019s syndrome fueled by inflammagenic DNA accumulations","volume":"91","author":"Vakrakou","year":"2018","journal-title":"J. Autoimmun."},{"issue":"5","key":"10.1016\/j.biopha.2020.110542_bib0710","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/joim.12115","article-title":"The P2X7 receptor-inflammasome complex has a role in modulating the inflammatory response in primary Sj\u00f6gren\u2019s syndrome","volume":"274","author":"Baldini","year":"2013","journal-title":"J. Intern. Med."},{"issue":"40","key":"10.1016\/j.biopha.2020.110542_bib0715","doi-asserted-by":"crossref","first-page":"16626","DOI":"10.1074\/jbc.M117.790741","article-title":"P2X7 receptor antagonism prevents IL-1\u03b2 release from salivary epithelial cells and reduces inflammation in a mouse model of autoimmune exocrinopathy","volume":"292","author":"Khalafalla","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2020.110542_bib0720","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/joim.12631","article-title":"The P2X7 receptor-NLRP3 inflammasome complex predicts the development of non-Hodgkin\u2019s lymphoma in Sjogren\u2019s syndrome: a prospective, observational, single-centre study","volume":"282","author":"Baldini","year":"2017","journal-title":"J. Intern. Med."},{"issue":"10103","key":"10.1016\/j.biopha.2020.110542_bib0725","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.biopha.2020.110542_bib0730","first-page":"5","article-title":"Expression of NLRP3 inflammasome, cytokines and vascular mediators in the skin of systemic sclerosis patients","volume":"17","author":"Mart\u00ednez-God\u00ednez","year":"2015","journal-title":"Isr. Med. Assoc. J.: IMAJ"},{"issue":"11","key":"10.1016\/j.biopha.2020.110542_bib0735","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1002\/art.30568","article-title":"The inflammasome activating caspase 1 mediates fibrosis and myofibroblast differentiation in systemic sclerosis","volume":"63","author":"Artlett","year":"2011","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.biopha.2020.110542_bib0740","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s13075-017-1331-z","article-title":"Mir-155 is overexpressed in systemic sclerosis fibroblasts and is required for NLRP3 inflammasome-mediated collagen synthesis during fibrosis","volume":"19","author":"Artlett","year":"2017","journal-title":"Arthritis Res. Ther."},{"issue":"6","key":"10.1016\/j.biopha.2020.110542_bib0745","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.jhep.2016.01.035","article-title":"The pro-inflammatory effects of miR-155 promote liver fibrosis and alcohol-induced steatohepatitis","volume":"64","author":"Bala","year":"2016","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.biopha.2020.110542_bib0750","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.bbrc.2010.08.067","article-title":"MicroRNA-155 regulates angiotensin II type 1 receptor expression and phenotypic differentiation in vascular adventitial fibroblasts","volume":"400","author":"Zheng","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2020.110542_bib0755","doi-asserted-by":"crossref","first-page":"20314","DOI":"10.1038\/srep20314","article-title":"Targeting miR-155 to treat experimental scleroderma","volume":"6","author":"Yan","year":"2016","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.biopha.2020.110542_bib0760","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/j.jid.2019.03.1144","article-title":"Effects of parvovirus B19 in vitro infection on monocytes from patients with systemic sclerosis: enhanced inflammatory pathways by caspase-1 activation and cytokine production","volume":"139","author":"Zakrzewska","year":"2019","journal-title":"J. Invest. Dermatol."},{"issue":"6","key":"10.1016\/j.biopha.2020.110542_bib0765","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nrrheum.2017.56","article-title":"Pathogenesis of ankylosing spondylitis - recent advances and future directions","volume":"13","author":"Ranganathan","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.biopha.2020.110542_bib0770","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.cca.2018.08.022","article-title":"NLRP3 inflammasomes and NLRP3 inflammasome-derived proinflammatory cytokines in peripheral blood mononuclear cells of patients with ankylosing spondylitis","volume":"486","author":"Kim","year":"2018","journal-title":"Clin. Chim. Acta"},{"issue":"9","key":"10.1016\/j.biopha.2020.110542_bib0775","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1080\/15548627.2018.1458804","article-title":"TNFAIP3-DEPTOR complex regulates inflammasome secretion through autophagy in ankylosing spondylitis monocytes","volume":"14","author":"Zhai","year":"2018","journal-title":"Autophagy"},{"issue":"3","key":"10.1016\/j.biopha.2020.110542_bib0780","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.biopha.2020.110542_bib0785","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41589-019-0277-7","article-title":"MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition","volume":"15","author":"Coll","year":"2019","journal-title":"Nat. Chem. Biol."},{"issue":"9","key":"10.1016\/j.biopha.2020.110542_bib0790","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000354","article-title":"MCC950\/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition","volume":"17","author":"Vande Walle","year":"2019","journal-title":"PLoS Biol."},{"issue":"2","key":"10.1016\/j.biopha.2020.110542_bib0795","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/cei.13167","article-title":"NLRP3 inflammasome activation contributes to the pathogenesis of rheumatoid arthritis","volume":"194","author":"Guo","year":"2018","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.biopha.2020.110542_bib0800","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109313","article-title":"Let-7f-5p ameliorates inflammation by targeting NLRP3 in bone marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus","volume":"118","author":"Tan","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.biopha.2020.110542_bib0805","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2174\/138161207780163006","article-title":"Inflammatory caspases: targets for novel therapies","volume":"13","author":"Cornelis","year":"2007","journal-title":"Curr. Pharm. Des."},{"issue":"10","key":"10.1016\/j.biopha.2020.110542_bib0810","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S1063-4584(03)00153-5","article-title":"Pralnacasan, an inhibitor of interleukin-1beta converting enzyme, reduces joint damage in two murine models of osteoarthritis","volume":"11","author":"Rudolphi","year":"2003","journal-title":"Osteoarthr. Cartil."},{"issue":"1","key":"10.1016\/j.biopha.2020.110542_bib0815","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/ar2555","article-title":"Randomized controlled trial design in rheumatoid arthritis: the past decade","volume":"11","author":"Strand","year":"2009","journal-title":"Arthritis Res. Ther."},{"issue":"2","key":"10.1016\/j.biopha.2020.110542_bib0820","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1124\/jpet.106.111344","volume":"321","author":"Wannamaker","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2020.110542_bib0825","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-med-061512-150641","article-title":"IL-1 blockade in autoinflammatory syndromes","volume":"65","author":"Jesus","year":"2014","journal-title":"Annu. Rev. Med."},{"issue":"7-8","key":"10.1016\/j.biopha.2020.110542_bib0830","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1345\/aph.1A396","article-title":"Anakinra treatment of patients with rheumatoid arthritis","volume":"36","author":"Calabrese","year":"2002","journal-title":"Ann. Pharmacother."},{"issue":"3","key":"10.1016\/j.biopha.2020.110542_bib0835","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1517\/13543784.17.3.349","article-title":"The future of the IL-1 receptor antagonist anakinra: from rheumatoid arthritis to adult-onset Still\u2019s disease and systemic-onset juvenile idiopathic arthritis","volume":"17","author":"Kalliolias","year":"2008","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"12","key":"10.1016\/j.biopha.2020.110542_bib0840","first-page":"e3782","article-title":"Anakinra for recurrent fevers in systemic lupus erythematosus","volume":"10","author":"Dein","year":"2018","journal-title":"Cureus"},{"key":"10.1016\/j.biopha.2020.110542_bib0845","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.3389\/fimmu.2019.01951","article-title":"Accelerated and severe lupus nephritis benefits from M1, an active metabolite of ginsenoside, by regulating NLRP3 inflammasome and t cell functions in mice","volume":"10","author":"Lin","year":"2019","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.biopha.2020.110542_bib0850","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/abbs\/gmy088","article-title":"mTOR regulates NLRP3 inflammasome activation via reactive oxygen species in murine lupus","volume":"50","author":"Li","year":"2018","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.biopha.2020.110542_bib0855","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111822","article-title":"Development of small molecule inhibitors targeting NLRP3 inflammasome pathway for inflammatory diseases","volume":"185","author":"Zhang","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2020.110542_bib0860","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.3389\/fimmu.2019.02538","article-title":"Pharmacological inhibitors of the NLRP3 inflammasome","volume":"10","author":"Zahid","year":"2019","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2020.110542_bib0865","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/1043-4666(92)90078-6","article-title":"Pharmacokinetics, safety and immunomodulatory effects of human recombinant interleukin-1 receptor antagonist in healthy humans","volume":"4","author":"Granowitz","year":"1992","journal-title":"Cytokine"},{"issue":"6","key":"10.1016\/j.biopha.2020.110542_bib0870","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.2165\/11599820-000000000-00000","article-title":"Pharmacokinetic and pharmacodynamic properties of canakinumab, a human anti-interleukin-1\u03b2 monoclonal antibody","volume":"51","author":"Chakraborty","year":"2012","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.biopha.2020.110542_bib0875","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1471-2474-12-153","article-title":"Efficacy and safety of the human anti-IL-1\u03b2 monoclonal antibody canakinumab in rheumatoid arthritis: results of a 12-week, Phase II, dose-finding study","volume":"12","author":"Alten","year":"2011","journal-title":"BMC Musculoskelet. Disord."},{"issue":"8","key":"10.1016\/j.biopha.2020.110542_bib0880","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1080\/17512433.2016.1204910","article-title":"Canakinumab for the treatment of active systemic juvenile idiopathic arthritis","volume":"9","author":"Orrock","year":"2016","journal-title":"Expert Rev. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2020.110542_bib0885","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.semarthrit.2012.03.004","article-title":"The use of Canakinumab, a novel IL-1\u03b2 long-acting inhibitor, in refractory adult-onset Still\u2019s disease","volume":"42","author":"Kontzias","year":"2012","journal-title":"Semin. Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.biopha.2020.110542_bib0890","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/art.33412","article-title":"Rilonacept (interleukin-1 trap) in the prevention of acute gout flares during initiation of urate-lowering therapy: results of a phase II randomized, double-blind, placebo-controlled trial","volume":"64","author":"Schumacher","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"7","key":"10.1016\/j.biopha.2020.110542_bib0895","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1093\/rheumatology\/ket114","article-title":"Rilonacept for gout flare prevention during initiation of uric acid-lowering therapy: results from the PRESURGE-2 international, phase 3, randomized, placebo-controlled trial","volume":"52","author":"Mitha","year":"2013","journal-title":"Rheumatology (Oxf. Engl.)"},{"issue":"10","key":"10.1016\/j.biopha.2020.110542_bib0900","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1002\/acr.21690","article-title":"Rilonacept (interleukin-1 trap) for prevention of gout flares during initiation of uric acid-lowering therapy: results from a phase III randomized, double-blind, placebo-controlled, confirmatory efficacy study","volume":"64","author":"Schumacher","year":"2012","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"10.1016\/j.biopha.2020.110542_bib0905","first-page":"15","article-title":"Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives","volume":"8","author":"Ozaki","year":"2015","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.biopha.2020.110542_bib0910","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.molimm.2017.02.013","article-title":"Autophagy and inflammasomes","volume":"86","author":"Harris","year":"2017","journal-title":"Mol. Immunol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220307356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220307356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T18:04:31Z","timestamp":1766081071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332220307356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":182,"alternative-id":["S0753332220307356"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110542","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of the NLRP3 inflammasome in autoimmune diseases","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110542","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"110542"}}